NASDAQ
Co-Diagnostics, Inc. (CODX) has a revenue compound annual growth rate of -61.60% over 5 years and 51.15% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.